Stockreport

SAB Biotherapeutics to Present at 2022 H.C. Wainwright Global Investment Conference

SAB Biotherapeutics, Inc.  (SABS) 
PDF SIOUX FALLS, S.D., May 12, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS), announced today its participation at the H.C. Wainwright Global Investment Conf [Read more]